Xilio Therapeutics, Inc. (XLO)

7.60 -0.32 (-4.04%) USD  |  NASDAQ  |  Apr 29, 13:57
More

Xilio Therapeutics Research and Development Expense (TTM) : 56.04M for Dec. 31, 2025

Research and Development Expense (TTM) Chart

View Research and Development Expense (TTM) for XLO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (TTM) Range, Past 5 Years

View Research and Development Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (TTM) Benchmarks

View Research and Development Expense (TTM) Benchmarks
Start Trial
Johnson & Johnson 14.99B
Merck & Co., Inc. 12.71B
Pfizer Inc. 10.25B
Verastem, Inc. 114.60M
Sensei Biotherapeutics, Inc. 13.28M